Delivery Order SPE2DB24D9113-SPE2DB25FEQDZ
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $37,659.45 to DMS Pharmaceutical Group Inc. for EXPAREL 266 mg/20 mL vials. The order was issued on September 11, 2025, with an ultimate completion date of October 2, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,107.10 to DMS Pharmaceutical Group Inc. on September 9, 2025, for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials. This delivery order represents a firm fixed-price contract with an ultimate completion date of September 30, 2025, and will be fulfilled from the vendor's location in Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an...
- The Defense Logistics Agency awarded a delivery order valued at $10,042.52 to DMS Pharmaceutical Group Inc. on September 11, 2025, for the supply of EXPAREL 266 mg/20 mL vials. EXPAREL is a liposomal bupivacaine formulation used for surgical site infiltration and nerve block anesthesia. This firm fixed-price delivery order, with an ultimate completion date of October 2, 2025, will be delivered to Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $25,106.30 to DMS Pharmaceutical Group Inc. for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials on August 28, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 19, 2025, will be fulfilled from the vendor's location in Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its status as a...
- The Defense Logistics Agency awarded a delivery order valued at $10,042.52 to DMS Pharmaceutical Group Inc. for EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials on September 23, 2025. This firm fixed-price delivery order is due for completion by October 15, 2025, with performance taking place at the vendor's location in Park Ridge, Illinois. The contract utilizes no set-aside designation, allowing the woman-owned small business to compete directly in the federal pharmaceutical supply market....
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,521.66 to DMS Pharmaceutical Group Inc. for the supply of EXPAREL 133mg/10ml (10 units). The award was issued on August 7, 2025, with an ultimate completion date of August 26, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery from its Park Ridge location. This delivery order carries no set-aside designation...
- The Defense Logistics Agency awarded a $15,063.78 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on June 18, 2025, for the supply of EXPAREL 266 mg/20 mL vials. EXPAREL is a liposomal bupivacaine local anesthetic used for infiltration and nerve block procedures in surgical settings. The delivery order, which carries an ultimate completion date of July 11, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $125,531.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials. This firm fixed-price delivery order, issued on July 11, 2025, with an ultimate completion date of August 1, 2025, represents a direct procurement with no set-aside designation. The award falls under DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, valued at $15,063.78 with an ultimate completion date of October 9, 2025, was issued without a set-aside designation. The award leverages DMS Pharmaceutical Group's position as a critical supplier within the federal pharmaceutical supply...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials. The contract, valued at approximately $25.1K, carries an ultimate completion date of September 29, 2025, and was issued on September 8, 2025. This delivery order does not utilize a set-aside designation, allowing DMS Pharmaceutical Group...
- SPE2DB24D9113Indefinite Delivery Contract
- SPE2DB24D9113-SPE2DB25FEQDZDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $12,553.15 to DMS Pharmaceutical Group Inc. for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials. This award, issued on September 23, 2025, with an ultimate completion date of October 15, 2025, represents a single delivery order without set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the contract at its Illinois location. EXPAREL is a long-acting local anesthetic commonly used in surgical and pain management applications across military healthcare facilities. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency's SPE2DB program, valued at $499.999 billion through November 2026. This IDC enables DLA to procure a comprehensive portfolio of pharmaceutical products, including prescription medications, biologics, and medical consumables to support military health facilities worldwide. As a established federal supplier since 2001, DMS Pharmaceutical Group has demonstrated consistent capability in delivering specialized pharmaceutical products to Department of Defense healthcare sites, positioning the company as a critical resource within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.6k | 9/23/25 |